Cargando…
Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation
BACKGROUND: TNF-α-stimulated gene 6 (TSG-6) protein, a TNF-α-responsive hyaladherin, possesses enzymatic activity that can catalyze covalent crosslinks of the polysaccharide hyaluronic acid (HA) to another protein to form heavy chain-hyaluronic acid (HC-HA) complexes in pathological conditions such...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377964/ https://www.ncbi.nlm.nih.gov/pubmed/34416923 http://dx.doi.org/10.1186/s13075-021-02588-7 |
_version_ | 1783740746198679552 |
---|---|
author | Fasanello, Diana C. Su, Jin Deng, Siyu Yin, Rose Colville, Marshall J. Berenson, Joshua M. Kelly, Carolyn M. Freer, Heather Rollins, Alicia Wagner, Bettina Rivas, Felipe Hall, Adam R. Rahbar, Elaheh DeAngelis, Paul L. Paszek, Matthew J. Reesink, Heidi L. |
author_facet | Fasanello, Diana C. Su, Jin Deng, Siyu Yin, Rose Colville, Marshall J. Berenson, Joshua M. Kelly, Carolyn M. Freer, Heather Rollins, Alicia Wagner, Bettina Rivas, Felipe Hall, Adam R. Rahbar, Elaheh DeAngelis, Paul L. Paszek, Matthew J. Reesink, Heidi L. |
author_sort | Fasanello, Diana C. |
collection | PubMed |
description | BACKGROUND: TNF-α-stimulated gene 6 (TSG-6) protein, a TNF-α-responsive hyaladherin, possesses enzymatic activity that can catalyze covalent crosslinks of the polysaccharide hyaluronic acid (HA) to another protein to form heavy chain-hyaluronic acid (HC-HA) complexes in pathological conditions such as osteoarthritis (OA). Here, we examined HA synthase and inflammatory gene expression; synovial fluid HA, TNF-α, and viscosity; and TSG-6-mediated HC-HA complex formation in an equine OA model. The objectives of this study were to (1) evaluate the TNF-α-TSG-6-HC-HA signaling pathway across multiple joint tissues, including synovial membrane, cartilage, and synovial fluid, and (2) determine the impact of OA on synovial fluid composition and biophysical properties. METHODS: HA and inflammatory cytokine concentrations (TNF-α, IL-1β, CCL2, 3, 5, and 11) were analyzed in synovial fluid from 63 OA and 25 control joints, and HA synthase (HAS1-3), TSG-6, and hyaluronan-degrading enzyme (HYAL2, HEXA) gene expression was measured in synovial membrane and cartilage. HA molecular weight (MW) distributions were determined using agarose gel electrophoresis and solid-state nanopore measurements, and HC-HA complex formation was detected via immunoblotting and immunofluorescence. SEC-MALS was used to evaluate TSG-6-mediated HA crosslinking, and synovial fluid and HA solution viscosities were analyzed using multiple particle-tracking microrheology and microfluidic measurements, respectively. RESULTS: TNF-α concentrations were greater in OA synovial fluid, and TSG6 expression was upregulated in OA synovial membrane and cartilage. TSG-6-mediated HC-HA complex formation was greater in OA synovial fluid and tissues than controls, and HC-HA was localized to both synovial membrane and superficial zone chondrocytes in OA joints. SEC-MALS demonstrated macromolecular aggregation of low MW HA in the presence of TSG-6 and inter-α-inhibitor with concurrent increases in viscosity. CONCLUSIONS: Synovial fluid TNF-α concentrations, synovial membrane and cartilage TSG6 gene expression, and HC-HA complex formation were increased in equine OA. Despite the ability of TSG-6 to induce macromolecular aggregation of low MW HA with resultant increases in the viscosity of low MW HA solutions in vitro, HA concentration was the primary determinant of synovial fluid viscosity rather than HA MW or HC-HA crosslinking. The TNF-α-TSG-6-HC-HA pathway may represent a potential therapeutic target in OA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02588-7. |
format | Online Article Text |
id | pubmed-8377964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-83779642021-08-23 Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation Fasanello, Diana C. Su, Jin Deng, Siyu Yin, Rose Colville, Marshall J. Berenson, Joshua M. Kelly, Carolyn M. Freer, Heather Rollins, Alicia Wagner, Bettina Rivas, Felipe Hall, Adam R. Rahbar, Elaheh DeAngelis, Paul L. Paszek, Matthew J. Reesink, Heidi L. Arthritis Res Ther Research Article BACKGROUND: TNF-α-stimulated gene 6 (TSG-6) protein, a TNF-α-responsive hyaladherin, possesses enzymatic activity that can catalyze covalent crosslinks of the polysaccharide hyaluronic acid (HA) to another protein to form heavy chain-hyaluronic acid (HC-HA) complexes in pathological conditions such as osteoarthritis (OA). Here, we examined HA synthase and inflammatory gene expression; synovial fluid HA, TNF-α, and viscosity; and TSG-6-mediated HC-HA complex formation in an equine OA model. The objectives of this study were to (1) evaluate the TNF-α-TSG-6-HC-HA signaling pathway across multiple joint tissues, including synovial membrane, cartilage, and synovial fluid, and (2) determine the impact of OA on synovial fluid composition and biophysical properties. METHODS: HA and inflammatory cytokine concentrations (TNF-α, IL-1β, CCL2, 3, 5, and 11) were analyzed in synovial fluid from 63 OA and 25 control joints, and HA synthase (HAS1-3), TSG-6, and hyaluronan-degrading enzyme (HYAL2, HEXA) gene expression was measured in synovial membrane and cartilage. HA molecular weight (MW) distributions were determined using agarose gel electrophoresis and solid-state nanopore measurements, and HC-HA complex formation was detected via immunoblotting and immunofluorescence. SEC-MALS was used to evaluate TSG-6-mediated HA crosslinking, and synovial fluid and HA solution viscosities were analyzed using multiple particle-tracking microrheology and microfluidic measurements, respectively. RESULTS: TNF-α concentrations were greater in OA synovial fluid, and TSG6 expression was upregulated in OA synovial membrane and cartilage. TSG-6-mediated HC-HA complex formation was greater in OA synovial fluid and tissues than controls, and HC-HA was localized to both synovial membrane and superficial zone chondrocytes in OA joints. SEC-MALS demonstrated macromolecular aggregation of low MW HA in the presence of TSG-6 and inter-α-inhibitor with concurrent increases in viscosity. CONCLUSIONS: Synovial fluid TNF-α concentrations, synovial membrane and cartilage TSG6 gene expression, and HC-HA complex formation were increased in equine OA. Despite the ability of TSG-6 to induce macromolecular aggregation of low MW HA with resultant increases in the viscosity of low MW HA solutions in vitro, HA concentration was the primary determinant of synovial fluid viscosity rather than HA MW or HC-HA crosslinking. The TNF-α-TSG-6-HC-HA pathway may represent a potential therapeutic target in OA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02588-7. BioMed Central 2021-08-20 2021 /pmc/articles/PMC8377964/ /pubmed/34416923 http://dx.doi.org/10.1186/s13075-021-02588-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Fasanello, Diana C. Su, Jin Deng, Siyu Yin, Rose Colville, Marshall J. Berenson, Joshua M. Kelly, Carolyn M. Freer, Heather Rollins, Alicia Wagner, Bettina Rivas, Felipe Hall, Adam R. Rahbar, Elaheh DeAngelis, Paul L. Paszek, Matthew J. Reesink, Heidi L. Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation |
title | Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation |
title_full | Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation |
title_fullStr | Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation |
title_full_unstemmed | Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation |
title_short | Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation |
title_sort | hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: tnf-α-tsg-6-mediated hc-ha formation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377964/ https://www.ncbi.nlm.nih.gov/pubmed/34416923 http://dx.doi.org/10.1186/s13075-021-02588-7 |
work_keys_str_mv | AT fasanellodianac hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation AT sujin hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation AT dengsiyu hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation AT yinrose hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation AT colvillemarshallj hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation AT berensonjoshuam hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation AT kellycarolynm hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation AT freerheather hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation AT rollinsalicia hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation AT wagnerbettina hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation AT rivasfelipe hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation AT halladamr hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation AT rahbarelaheh hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation AT deangelispaull hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation AT paszekmatthewj hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation AT reesinkheidil hyaluronicacidsynthesisdegradationandcrosslinkinginequineosteoarthritistnfatsg6mediatedhchaformation |